2005 No. 2789
MEDICINES
The Medicines for Human Use (Manufacturing, Wholesale Dealing and Miscellaneous Amendments) Regulations 2005
Made 10th October 2005
Laid before Parliament 10th October 2005
Coming into force 30th October 2005

The Secretary of State, being a Minister designated for the purposes of section 2(2) of the European Communities Act 1972 in relation to medicinal products, in exercise of the powers conferred on her by the said section 2(2), and the Secretary of State, the Department of Health, Social Services and Public Safety and the Department of Agriculture and Rural Development, acting jointly, in exercise of the powers conferred on them by sections 18(1), 47(1) and 129(1) and (5) of the Medicines Act 1968 or, as the case may be, the powers conferred by those provisions and now vested in them, make the following Regulations.
S.I.1972/181.
1972 c. 68.
1968 c. 67; the expression “the Ministers”, which is relevant to the powers being exercised in the making of these Regulations, is defined in section 1 of that Act as amended by article 2(2) of, and Schedule 1 to, S.I.1969/388, by articles 2(1) and 5 of, and the Schedule to, S.I.1999/3142, and by article 5(1) of, and paragraph 15 of Schedule 1 to, S.I.2002/794.
In the case of the Secretary of State, by virtue of article 2(2) of, and Schedule 1 to, S.I.1969/388, article 2(1) of, and paragraph 1 of the Schedule to, S.I.1999/3142, and article 3(1)(c) and (7) of, and paragraph 15 of Schedule 1 to, S.I.2002/794; in the case of the Northern Ireland Departments, the powers vested in the Ministers in charge of those Departments by virtue of section 95(5) of, and paragraph 10 of Schedule 12 to, the Northern Ireland Act 1998 (c. 47) may now be exercised by the Departments by virtue of section 1(8) of, and paragraph 4(1)(b) of the Schedule to, the Northern Ireland Act 2000 (c. 1); the Departments were renamed by virtue of article 3(4) and (6) of S.I.1999/283 (N.I.1).
In accordance with section 129(6) of the Medicines Act 1968, they have consulted with such organisations as appear to them to be representative of interests likely to be substantially affected by these Regulations.